Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
CITIUS ONCOLOGY, INC.Citius Oncology Reports Increased Net Loss and Prepares for LYMPHIR Launch
PRECIGEN, INC.Precigen Reports 19.4% Revenue Growth in Q2 2025, Despite $26.6M Net Loss
Kodiak AI, Inc.Ares Acquisition Corporation II Reports Significant Decline in Net Income for Q2 2025
IRIDEX CORPIRIDEX Reports 7.4% Revenue Growth in Q2 2025, Net Loss Improves
Erasca, Inc.Erasca Reports $33.9 Million Net Loss in Q2 2025, Down from $63.2 Million Last Year
GCT Semiconductor Holding, Inc.GCT Semiconductor Reports 19% Revenue Decline in Q2 2025, Faces Financial Challenges
FLANIGANS ENTERPRISES INCFlanigan's Enterprises Reports 6.24% Revenue Growth to $52.2 Million
GoHealth, Inc.GoHealth Reports Q2 2025 Revenue Decline and Significant Net Loss
Fathom Holdings Inc.Fathom Holdings Reports 36% Revenue Growth to $121.4 Million in Latest Quarter
Virginia National Bankshares CorpVirginia National Bankshares Reports Q2 2025 Financial Results with $4.2 Million Net Income
Lyra Therapeutics, Inc.Lyra Therapeutics Reports Decrease in Collaboration Revenue and Improved Net Loss in Latest 10-Q Filing
GBank Financial Holdings Inc.GBank Financial Holdings Reports $4.8 Million Net Income for Q2 2025
MEXCO ENERGY CORPMexco Energy Corporation Reports Q2 2025 Financial Results with Increased Revenues and Decreased Net Income
SPRUCE POWER HOLDING CORPSpruce Power Reports 48% Revenue Growth to $33.2 Million in Q2 2025
Verrica Pharmaceuticals Inc.Verrica Pharmaceuticals Reports $12.7M Revenue and $204K Net Income in Q2 2025
Oric Pharmaceuticals, Inc.ORIC Pharmaceuticals Reports $36.4 Million Net Loss in Q2 2025, Increases Focus on Key Clinical Programs
OnKure Therapeutics, Inc.OnKure Therapeutics Reports $31.3 Million Net Loss for First Half of 2025
CARPENTER TECHNOLOGY CORPCarpenter Technology Reports 4% Revenue Growth to $2.877 Billion for Fiscal Year Ending June 30, 2025
Madison Square Garden Sports Corp.Madison Square Garden Sports Reports 1% Revenue Increase but Posts $22.4 Million Net Loss
PROKIDNEY CORP.ProKidney Reports $221,000 Revenue in Q2 2025, Continues to Operate at a Loss
Intellicheck, Inc.Intellicheck Reports 10% Revenue Growth in Q2 2025, Net Loss Increases
Pulse Biosciences, Inc.Pulse Biosciences Reports $19.2 Million Net Loss and No Revenue in Latest Quarter
Nkarta, Inc.Nkarta Reports Q2 2025 Financial Results with Reduced Net Loss and Increased Cash Reserves
TRAVELZOOTravelzoo Reports 13% Revenue Growth to $23.9 Million in Q2 2025
Global Gas CorpGlobal Gas Corporation Reports First Revenue Recognition and Decrease in Net Income for Q2 2025